Studies on the Efficacy and Safety of Deferasirox for Iron Chelation in Patients with MDS: EPIC and US03

Lenalidomide Activity in AML with Trisomy 13

Patterns of Care Survey for Acute Myeloid Leukemia (AML)

Five-Day Decitabine Therapy for Elderly Patients with Acute Myeloid Leukemia (AML)

CIBMTR Analysis of HCT in Older Patients with AML or MDS

New Prognostic Markers in Acute Myeloid Leukemia (AML)

Phase II Study of Clofarabine for Older Patients with Treatment-Naïve AML

A Prognostic Model for MDS that Accounts for Events Not Considered by the International Prognostic Scoring System (IPSS)

Three Alternate Dosing Schedules of Azacitidine for MDS

EORTC-06011: Low-Dose Decitabine versus Best Supportive Care for Elderly Patients with Intermediate- or High-Risk MDS

Myelodysplastic Syndromes

Azacitidine Before Allogeneic Hematopoietic Cell Transplantation (AHCT) for Myelodysplasias

Anthracycline Dose Intensification in Acute Myeloid Leukemia (AML)

Outcome of Myelodysplastic Syndrome (MDS) with and without
Chromosome 5 Abnormalities

Efficacy of Azacitidine in Higher-Risk Myelodysplastic Syndrome (MDS)